GlassScriptPhysician profile
Ellen Michelle Mlot
NPI 1447516638
$1,235.52
in general payments reported to CMS, 2019-2025
22 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $46.25 · 2021: $257 · 2022: $184 · 2023: $150 · 2024: $227 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $160.19 | 2019-2024 | Gardasil 9, M-M-R II, Vaxneuvance |
| Sanofi Pasteur INC. | $122.71 | 2019-2025 | |
| Sobi, INC | $115.79 | 2019-2023 | |
| Cranial Technologies, INC | $109.08 | 2019-2025 | Doc Band |
| Kaleo, INC. | $104.57 | 2019-2023 | Auvi-Q |
| Ultragenyx Pharmaceutical INC. | $71.77 | 2021-2024 | Crysvita |
| Ironshore Pharmaceuticals INC. | $71.19 | 2019-2024 | |
| Seqirus USA INC | $59.78 | 2023-2025 | Flucelvax Quadrivalent, Flucelvax |
| Pfizer INC. | $56.92 | 2022-2025 | |
| Glaxosmithkline, LLC. | $51.41 | 2019-2021 | |
| Biomarin Pharmaceutical INC. | $48.19 | 2022-2025 | Voxzogo 1.2mg |
| Takeda Pharmaceuticals U.S.A., INC. | $46.49 | 2021 | |
| Shire North American Group INC | $34.60 | 2019 | |
| Mirum Pharmaceuticals, INC. | $29.97 | 2025 | Livmarli |
| Verrica Pharmaceuticals INC. | $24.81 | 2024 | Ycanth |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $24.57 | 2021 | |
| Corium, LLC | $24.23 | 2022 | |
| Alk-Abello, INC | $20.18 | 2025 | Neffy |
| Tris Pharma INC | $18.17 | 2024 | Onyda Xr |
| Dermira, INC. | $15.03 | 2020 | |
| Nestle Healthcare Nutrition INC. | $13.87 | 2023 | |
| Alexion Pharmaceuticals, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Mlot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.